The clock started ticking today on tighter new regulations for the medical device and in vitro diagnostic industries in Europe when the European Commission published the new rules. The regulations, approved last month by the European Parliament, include stronger post-market surveillance rules and adding a safety check for high-risk devices. The new EU rules, which also mandate […]
European Commission
European anti-trust regulators grant conditional approval for Abbott’s $25B St. Jude Medical buy
Anti-trust regulators in the European Union last week granted conditional approval for the $25 billion merger of Abbott (NYSE:ABT) and St. Jude Medical (NYSE:STJ). The European Commission’s decision on the deal requires the divestiture of a pair of device lines: St. Jude must deal its Angio-Seal and Femoseal vascular closure assets, including a manufacturing plant in Puerto Rico, and […]
Report: EU regulators poised to OK Abbott’s $25B St. Jude Medical acquisition
Antitrust regulators in the European Union are reportedly poised to give conditional clearance to the $25 billion merger of Abbott (NYSE:ABT) and St. Jude Medical (NYSE:STJ). The European Commission has until next week to make its decision on the deal, after the companies earlier this month made concessions designed to assuage the commission’s monopoly fears. Abbott and St. Jude agreed last […]
MDT buys hearing aid maker Sophono | The week in medtech M&A
European regulators OK $13B Zimmer-Biomet deal
ZMH set to acquire EU approval for $13B Biomet deal | The week in medtech M&A
Report: EU to clear Zimmer’s $13B Biomet deal
Medtronic clears all anti-trust hurdles for Covidien acquisition
ZMH proposes to mollify EU anti-trust regulators on pending, $13B acquisition Biomet | The week in medtech M&A
Zimmer proposes divestitures for EU regulators in Biomet deal
EU, Zimmer agree to extend review of Biomet merger
